SG11202009601XA - Anti-stress composition - Google Patents

Anti-stress composition

Info

Publication number
SG11202009601XA
SG11202009601XA SG11202009601XA SG11202009601XA SG11202009601XA SG 11202009601X A SG11202009601X A SG 11202009601XA SG 11202009601X A SG11202009601X A SG 11202009601XA SG 11202009601X A SG11202009601X A SG 11202009601XA SG 11202009601X A SG11202009601X A SG 11202009601XA
Authority
SG
Singapore
Prior art keywords
stress composition
stress
composition
Prior art date
Application number
SG11202009601XA
Other languages
English (en)
Inventor
Yodai Kobayashi
Hazuki MAEHATA
Tetsuya Kuhara
Atsushi Toyoda
Original Assignee
Morinaga Milk Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morinaga Milk Industry Co Ltd filed Critical Morinaga Milk Industry Co Ltd
Publication of SG11202009601XA publication Critical patent/SG11202009601XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202009601XA 2018-03-27 2019-03-25 Anti-stress composition SG11202009601XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018060637 2018-03-27
PCT/JP2019/012303 WO2019188868A1 (ja) 2018-03-27 2019-03-25 抗ストレス用組成物

Publications (1)

Publication Number Publication Date
SG11202009601XA true SG11202009601XA (en) 2020-10-29

Family

ID=68061968

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009601XA SG11202009601XA (en) 2018-03-27 2019-03-25 Anti-stress composition

Country Status (7)

Country Link
US (1) US20210000894A1 (de)
EP (1) EP3782632A4 (de)
JP (2) JPWO2019188868A1 (de)
CN (1) CN112020364A (de)
AU (1) AU2019244232A1 (de)
SG (1) SG11202009601XA (de)
WO (1) WO2019188868A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022196488A1 (ja) * 2021-03-15 2022-09-22 森永乳業株式会社 Qolを改善するための組成物
CN113430135B (zh) * 2021-07-01 2022-04-26 杭州娃哈哈科技有限公司 一种有改善抑郁作用的瑞士乳杆菌菌株及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4065038B2 (ja) * 1996-08-07 2008-03-19 カルピス株式会社 計算作業負荷ストレス緩和剤
WO2006048446A1 (en) * 2004-11-05 2006-05-11 Dsm Ip Assets B.V. Lactobacillus for preventing and/or treating chronique fatigue syndrome and associated diseases
JP2010030901A (ja) 2006-11-17 2010-02-12 Kaneka Corp ストレス症状の緩和または予防剤
CN103221531B (zh) * 2010-11-09 2018-03-16 朝日集团控股株式会社 具有高蛋白质水解活性的瑞士乳杆菌
JP5965875B2 (ja) * 2013-08-30 2016-08-10 森永乳業株式会社 D−アミノ酸の製造方法

Also Published As

Publication number Publication date
AU2019244232A1 (en) 2020-11-19
US20210000894A1 (en) 2021-01-07
JPWO2019188868A1 (ja) 2021-03-18
CN112020364A (zh) 2020-12-01
JP2024091698A (ja) 2024-07-05
EP3782632A4 (de) 2021-12-15
EP3782632A1 (de) 2021-02-24
WO2019188868A1 (ja) 2019-10-03

Similar Documents

Publication Publication Date Title
SG11202012734YA (en) Composition
GB201911800D0 (en) Antiflouling Composition
GB201820878D0 (en) Composition
GB201811100D0 (en) Composition
GB2606975B (en) Composition
GB201804434D0 (en) Composition
SG11202011204PA (en) Composition
SG11202009601XA (en) Anti-stress composition
GB2583851B (en) Composition
SG11202100878SA (en) Oil-and-fat composition
GB201909924D0 (en) Composition
GB201901161D0 (en) Composition
GB201818827D0 (en) Composition
PL3571933T3 (pl) Kompozycja
SG11202011908YA (en) Delamanid-containing composition
GB201819861D0 (en) Composition
GB201815032D0 (en) Composition
GB201810024D0 (en) Composition
GB201809123D0 (en) Composition
GB201801596D0 (en) Composition
SG11202105547RA (en) Composition
SG11202105335UA (en) Composition
SG11202105334QA (en) Composition
GB201913398D0 (en) Composition
GB201820082D0 (en) Composition